featured news

Friday, July 1, 2022

Line 3 Mock-up

read more

feature 1

featured news

feature 2

featured news

feature 3

featured news

feature 5

our technological excellence as a CDMO

We are oncomed – a Contract Development and Manufacturing Organization (CDMO) specialized in aseptic processing of oncology injectables in clinical and commercial scales. We deliver drugs with high potent and cytotoxic characteristics to fight cancer, worldwide.

organic solvents handling

high-potent APIs

single-use systems

sensitive API handling

5 reasons why choose oncomed

5 reasons why choose oncomed

employee skills & mindset

We believe that thanks to our knowledge, flexible approach and endeavour to look for the solution, we may fully support a clients in their needs.

variety of niche technologies

We believe that thanks to our brave approach and state-of-the-art technology, our clients can dare to act with courage too and ask for advanced highly active drug solutions. We (and our technology) will support them.

supply risk mitigation

We understand the cost and time pressures faced by pharmaceutical companies, therefore we offer flexible, affordable, and rapid outsourcing services designed to meet specific needs of our customers.

access to free manufacturing capacity

We offer two fully operational lines. We also keep investing into manufacturing capacity and state-of-the-art technologies. Line 3 that will offer highly advanced solutions is in construction.

no additional major investments

We offer various vial formats, variable equipment sizes and qualified processes. We also take pride in our transparent service offerings that lower any additional investments to a mere minimum.

employee skills & mindset

We believe that thanks to our knowledge, flexible approach and endeavour to look for the solution, we may fully support a clients in their needs.

variety of niche technologies

We believe that thanks to our brave approach and state-of-the-art technology, our clients can dare to act with courage too and ask for advanced highly active drug solutions. We (and our technology) will support them.

supply risk mitigation

We understand the cost and time pressures faced by pharmaceutical companies, therefore we offer flexible, affordable, and rapid outsourcing services designed to meet specific needs of our customers.

access to free manufacturing capacity

We offer two fully operational lines. We also keep investing into manufacturing capacity and state-of-the-art technologies. Line 3 that will offer highly advanced solutions is in construction.

no additional major investments

We offer various vial formats, variable equipment sizes and qualified processes. We also take pride in our transparent service offerings that lower any additional investments to a mere minimum.

upcoming events

CPhI Worldwide 2022

conference, networking

01 Nov – 03 Nov 2022

Frankfurt, Germany

Each year CPhI unites more than 100,000 pharmaceutical professionals through exhibitions, conferences and online communities to network, identify business opportunities and expand the global market.

news & stories

24. 6. 2022 | News

Business mission to the USA

oncomed manufacturing, together with 25 other companies from various industries, had the opportunity to take part in a business mission to the USA led by the Confederation of Industry of the Czech Republic. Together, the companies accompanied the President of the Senate, Miloš Vystrčil on his official visit to the United States in Chicago, Washington, D.C. and Richmond, the state capital of Virginia.
read text
12. 5. 2022 | Articles

Line 3 Mock-up

After many years of planning and designing, we have successfully completed the mock-up of Line 3. Read the article about the process and challenges we were facing.
read text
10. 3. 2022 | Articles

Implementation of IDM in oncomed

What is the Indentity Management and what was our jouney during the implementation? Article focused on importance of IDM.
read text